Name: Latest research reports of Rossari Biotech Ltd. authored by Edelweiss and published by - Trendlyne research reports.
Item: Rossari Biotech Ltd.
Rating: 5
Author: Edelweiss

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	28 Mar 2025	Rossari Biotech	Consensus Share Price Target	604.65	901.33	-	49.07	buy	pdf Detailed Estimates
	11 Nov 2022	Rossari Biotech	Edelweiss Target	604.65	1170.00	827.80 (-26.96%)		Buy	pdf post cache	Broker Report Rossari Biotech Ltd \| Q2FY23 Result Update Edelweiss Synergies and product introductions to drive long-term growth pdf Copy Link Share on Share on Share on Share on Alert
	09 Nov 2022	Rossari Biotech	ICICI Securities Limited Target	604.65	870.00	834.05 (-27.50%)	Target met	Hold	pdf post cache	Broker Report After margins, revenue has headwinds now! ICICI Securities Limited Rossari Biotech’s Q2FY23 result disappointed on margins despite raw material price correction, and now company is cautious on revenue growth. We are disappointed at revenue growth performance across segments of standalone business. pdf Copy Link Share on Share on Share on Share on Alert
	11 Aug 2022	Rossari Biotech	Edelweiss	604.65	1150.00	927.90 (-34.84%)		Buy	pdf post cache	Broker Report Rossari Biotech Ltd. \| Q1FY23 Result Update Edelweiss Margins inching up, 2H expected to be stronger pdf Copy Link Share on Share on Share on Share on Alert
	10 Aug 2022	Rossari Biotech	ICICI Securities Limited Target	604.65	920.00	934.80 (-35.32%)	Target met	Hold	pdf post cache	Broker Report Protecting margins; revenue growth tepid ICICI Securities Limited Rossari Biotech’s Q1FY23 result was a mixed print with weak revenue (standalone revenue dipped 11% QoQ / up 15% YoY), while margin displayed sharp recovery (gross profit margin up 300bps QoQ). pdf Copy Link Share on Share on Share on Share on Alert
	10 Aug 2022	Rossari Biotech	KRChoksey	604.65	1252.00	934.80 (-35.32%)		Buy	pdf post cache	Broker Report Building product pipeline to drive the business growth KRChoksey Rossari Biotech consolidate revenue grew by 88% YoY at INR 4,347Mn (5% below KRC estimates) which includes mergers’ impact and can’t be compared directly with Q1FY22. pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2022	Rossari Biotech	Yes Securities	604.65	1355.00	885.05 (-31.68%)		Buy	pdf post cache	Broker Report Rossari Yes Securities pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2022	Rossari Biotech	KRChoksey	604.65	1252.00	885.05 (-31.68%)		Buy	pdf post cache	Broker Report Rossari KRChoksey pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2022	Rossari Biotech	Edelweiss Target	604.65	1150.00	890.55 (-32.10%)		Buy	pdf post cache	Broker Report Rossari Biotech Ltd \| Q4FY22 Result Update Edelweiss Acquired businesses outperform, Outlook Positive pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2022	Rossari Biotech	ICICI Securities Limited	604.65	910.00	888.75 (-31.97%)	Target met	Hold	pdf post cache	Broker Report Company putting in efforts to normalize margins ICICI Securities Limited Rossari Biotech’s Q4FY22 standalone EBITDA dipped 20% YoY to Rs275mn, and standalone HPPC revenues fell 13% QoQ – which were unimpressive. However, the performance of acquired companies was steady, and this helped consolidated EBITDA growth of 49% YoY to Rs523mn. pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2022	Rossari Biotech	Edelweiss Target	604.65	1225.00	1052.60 (-42.56%)		Buy	pdf post cache	Broker Report Rossari Biotech Ltd \| Q3FY22 Result Update Edelweiss Input cost inflation continues to weigh on margins pdf Copy Link Share on Share on Share on Share on Alert
more loading

37.84% Fall from 52W High

High volume today

Rossari Biotech Ltd. share price target

Rossari Biotech Ltd. has an average target of 939.75. The consensus estimate represents an upside of 55.42% from the last price of 604.65. View 9 reports from 4 analysts offering long-term price targets for Rossari Biotech Ltd..

Rossari Biotech Ltd | Q2FY23 Result Update

After margins, revenue has headwinds now!

Rossari Biotech Ltd. | Q1FY23 Result Update

Protecting margins; revenue growth tepid

Building product pipeline to drive the business growth

Rossari

Rossari

Rossari Biotech Ltd | Q4FY22 Result Update

Company putting in efforts to normalize margins

Rossari Biotech Ltd | Q3FY22 Result Update

Advisor Screeners